Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. - Wikidata - awgldk - TriplyDB

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

http://www.wikidata.org/entity/Q37367719

about

Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?Evidence for the prevention and treatment of stroke in dialysis patients Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis Cost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs.Anticoagulation Therapy in Patients with Chronic Kidney Disease.Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients Cardiovascular disease in CKD in 2012: moving forward, slowly but surely.Stroke in Patients with Chronic Kidney Disease…: How do we Approach and Manage it?Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes Intersection of cardiovascular disease and kidney disease: atrial fibrillation.Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.Rapidly progressive severe vascular calcification sparing the kidney allograft following warfarin initiation.The debate on warfarin use in dialysis patients with atrial fibrillation: more fuel for the fire.Digoxin associates with mortality in ESRD.The increasing prevalence of atrial fibrillation among hemodialysis patients.Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.Heparin use in hemodialysis patients following gastrointestinal bleeding.Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study.Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty.Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.Anticoagulation in chronic kidney disease patients-the practical aspects.Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Prevalence and Impact on Stroke in Patients Receiving Maintenance Hemodialysis versus Peritoneal Dialysis: A Prospective Observational Study.Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis.Warfarin in atrial fibrillation patients with moderate chronic kidney disease Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis.Dealing with prognostic signature instability: a strategy illustrated for cardiovascular events in patients with end-stage renal disease Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).A hemodialysis cohort study of protocol-based anticoagulation management.Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis Anticoagulants and acute kidney injury: clinical and pathology considerations.

P2860

Q26781181-6B8F16F1-46A3-4820-BE29-F07790B3ED4F Q26782013-1513249A-8DCC-4EC8-9480-394A0C10AFEC Q26801625-43000DBF-1468-43C9-99DD-E29030625C4E Q26827576-DBC125D5-0BA1-436E-9A49-3A7719A984E9 Q27006930-394890AC-9CDF-4F52-879D-3C9610351A4E Q27009350-C8DF40FD-3EFE-41E3-A957-8A31BF4CAE85 Q27010464-CBDDB545-0966-4B6F-8AC7-0E46F9261828 Q27023274-FA9876FD-891A-492E-9F88-46EDB5D47D73 Q27694667-BF7A80AD-4CFD-4C7E-A1CD-F59EA168DF9F Q28077393-2FDDF5CF-6BFC-4A21-8D24-7463D8FD82C4 Q33435357-82172B15-8EA3-4427-83B3-A313251E5C30 Q33617196-E0632740-27EF-448D-8410-D2B7CD0F30AA Q33682243-C9E22271-23FE-4197-85E2-1F971866E22C Q33697353-F7E2F0E1-0B3A-40F9-BBD6-EFB22E8B0E09 Q33827363-E51E814D-F957-4DC1-A69A-5CAF3A0C0A14 Q34040279-39A96C1D-48CF-4AA4-B884-7168E83D9E81 Q34241519-BAF9E08D-396A-4626-99C6-9CDCD500086B Q34348892-8D4F4754-ABC9-4C7A-8346-ED022B09DDF9 Q34403796-77C38C58-2FF1-40F4-BA0B-40EAF8A3E78D Q34455390-20574BCB-3791-4BCA-A86F-3C5C2B83DAFC Q34534916-2BFD22C6-CB63-49A1-9931-1EC17287F874 Q34534951-503E9AD5-0EF5-4D36-B42E-C464AF96D74F Q34580144-8A8E3EF9-3AC9-422D-8432-12EFD868FE92 Q34672695-F673134C-A686-488F-B96A-703784E2D6A0 Q34938763-B776735E-10F3-4333-9EED-13A2AE838B64 Q35187005-FF7D5D48-B007-434B-9409-A6196E5EBC71 Q35232128-E571A0E4-EEEB-412A-9D85-8A7166BA0F77 Q35499647-DD813A7F-02C0-49C7-83E7-B33E363E0B6B Q35609742-1B878EF8-6D26-454B-8D58-931CCFD41885 Q35814600-76611A4E-534A-4AA5-8213-84D994CF445F Q35846455-B3BF534B-C7B5-401E-A0F9-750A8214B840 Q35985876-0DC636C6-8015-495A-90C5-99378204C078 Q36069462-99FC4768-3F33-4864-8415-DF65635BFB12 Q36083333-54406A34-701D-4FA2-9300-328C6B3B6AC7 Q36096144-69A5DB2C-6631-4F2E-8F25-B926EAC82A63 Q36171135-2AFF6D18-C6EF-4B3F-A52C-AF11BDE04B5B Q36239524-3A498915-989F-4FAA-BCDC-7B57E63318A1 Q36261765-FDEC9D34-8A1A-4057-BE09-0E34D87ECC4F Q36353636-72281CB2-4817-4701-A3DE-38AE1AE4C699 Q36466324-F1B04FCE-8689-4DE5-A982-993644EABCE3

P2860

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

http://www.wikidata.org/entity/Q37367719

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Warfarin use associates with i ...... ents with atrial fibrillation.

@en

Warfarin use associates with i ...... ents with atrial fibrillation.

@nl

type

label

Warfarin use associates with i ...... ents with atrial fibrillation.

@en

Warfarin use associates with i ...... ents with atrial fibrillation.

@nl

prefLabel

Warfarin use associates with i ...... ents with atrial fibrillation.

@en

Warfarin use associates with i ...... ents with atrial fibrillation.

@nl

P1433

Q37367719-8219F640-4CA8-4675-86FA-C9AFD8931A54

P1476

Q37367719-CE4DB5E1-1C8E-4644-B246-2682DADF8B1F

P2093

Q37367719-65D344AE-55FE-4540-979E-188E5A46CA9D

Q37367719-6D8F56DD-9D31-4913-AE79-07E0CA979199

Q37367719-B348346D-08FA-426B-87A2-3C5B4A811428

Q37367719-FDC8FB7D-58AD-43FE-8B82-2184C0BD64D3

P2860

Q37367719-0C2482B2-3416-4DED-B277-90E39B5A4733

Q37367719-1351A6C8-CA51-4406-8314-50BB4968C15D

Q37367719-163DF5CA-3704-4CCD-8B29-8EEB25B791C1

Q37367719-20C75985-9119-416A-A5C8-A7BC336E5E6F

Q37367719-2337B638-ECC8-4DE1-9399-F8FAC4443298

Q37367719-2A2F5873-55F0-49E7-A70E-ED90EBEBEC1A

Q37367719-2D5B62ED-026E-4E9D-A0C3-FE1BBC1E594E

Q37367719-305C3780-C510-40A2-871A-92EE47389936

Q37367719-31344606-9E3B-4D6D-BDA9-F06097227260

Q37367719-36200F8A-097B-48AB-B9EB-40488A7AF340

P304

Q37367719-FD2D387E-4F35-4B98-9166-6674C125908C

P31

Q37367719-E215C291-2968-4284-AD3B-13C3EAF61161

P356

Q37367719-E764038B-5147-42B8-A7D0-1698062785DB

P433

Q37367719-BCCB8C50-8793-44DB-801C-D2E22102CBC7

P478

Q37367719-B5850B9A-B91B-4E8B-8440-FC1C4D7A6E04

P577

Q37367719-F02BA35A-CCBF-4A45-9479-201CCA0DFB6B

P698

Q37367719-0B12C4D7-E494-4807-BD39-94121EFEEDF3

P921

Q37367719-4D2778AC-7635-4931-9FBE-0E6BCAFC11A7

Q37367719-C045865E-3EC0-488A-9530-E2C3C8A98966

P932

Q37367719-A9E52CA7-8F10-4048-A3D5-818593A790E9

P356

P1433

Journal of the American Society of Nephrology

P1476

Warfarin use associates with i ...... ents with atrial fibrillation.

@en

P2093

J Michael Lazarus

http://www.w3.org/2001/XMLSchema#string

Kevin E Chan

http://www.w3.org/2001/XMLSchema#string

Ravi Thadhani

http://www.w3.org/2001/XMLSchema#string

Raymond M Hakim

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Primary prevention of ischemic stroke

Randomized, controlled trials, observational studies, and the hierarchy of research designs

Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management

Incidence of chronic atrial fibrillation in general practice and its treatment pattern

Cardioprotective medication use in hemodialysis patients

P304

2223-2233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2009030319

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19713308

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

2754104

http://www.w3.org/2001/XMLSchema#string